Study of Nitazoxanide in the Treatment of Clostridium Difficile-associated Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
The primary objective of the study is to demonstrate non-inferiority of nitazoxanide compared to vancomycin in resolving symptoms of Clostridium difficile-associated disease (CDAD).
Epistemonikos ID: 61f7fdd82ce6ace6cfc8dd48ea6f44639b3ba56c
First added on: May 04, 2024